跳至主要内容
临床试验/NCT00994409
NCT00994409已完成不适用

Berliner Schlaganfallregister - Nachbefragung Von Patienten Mit Schlaganfall

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2008年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,200
试验地点
1
主要终点
Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness.

研究概览

简要总结

The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.

详细描述

Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all patients eligible

排除标准

  • 未提供

结局指标

主要结局

Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness.

时间窗: September 2010

次要结局

  • Compliance/adherence with discharge medication Activities of daily living(September 2010)
  • Re-events(September 2010)
  • Degree of Disability(September 2010)
  • Mortality(September 2010)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验